Markets · Global Equities · US

ACTUATE THERAPEUTICS, INC. ACTU

Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.

• Revenue TTM —
• EBITDA TTM -22.05M
• Net debt —
• ND/EBITDA —
• EBITDA/interest -1089.1
• ROE -22.1
• Implied band B

All countries